Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Certara Community
NasdaqGS:CERT Community
1
Narratives
written by author
0
Comments
on narratives written by author
14
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
Certara
Popular
Undervalued
Overvalued
Certara
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
FDA Phaseout And AI Integration Will Expand Biosimulation Demand
Key Takeaways Regulatory shifts and long-term outsourcing trends are boosting demand for Certara's biosimulation and data-driven modeling solutions, supporting recurring revenue growth and market expansion. Strategic acquisitions, AI integration, and expanding cloud-based offerings are differentiating Certara's platform, improving margins, and enhancing client value and retention.
View narrative
US$15.22
FV
37.4% undervalued
intrinsic discount
9.16%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
14 days ago
author updated this narrative
Your Valuation for
CERT
CERT
Certara
Your Fair Value
US$
Current Price
US$9.53
17.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-61m
590m
2015
2018
2021
2024
2025
2027
2030
Revenue US$590.0m
Earnings US$77.4m
Advanced
Set Fair Value